These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


38 related items for PubMed ID: 2844486

  • 1. [Monoclonal antibodies against topoisomerase I inhibit cell entering into the phase of DNA synthesis].
    Kushch AA, Beliavskiĭ AV, Shumaĭ EP, Tugizov ShM, Ovcharenko AV.
    Dokl Akad Nauk SSSR; 1988; 300(4):968-71. PubMed ID: 2844486
    [No Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody and siRNAs for topoisomerase I suppress telomerase activity.
    Takahashi H, Kitagawa Y, Maeda-Satoh M, Hasegawa H, Sawa H, Sata T.
    Hybridoma (Larchmt); 2009 Feb; 28(1):63-5. PubMed ID: 19132895
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies against topoisomerase I suppressed DNA relaxation and HIV-1 cDNA synthesis.
    Takahashi H, Iwata T, Kitagawa Y, Shoya Y, Takahashi RH, Nagashima K, Kurata T.
    Hybridoma; 2000 Aug; 19(4):331-4. PubMed ID: 11001406
    [Abstract] [Full Text] [Related]

  • 4. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
    Gonchoroff NJ, Greipp PR, Kyle RA, Katzmann JA.
    Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes.
    Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM, Astaldi Ricotti GC.
    Exp Cell Res; 1992 Jun; 200(2):452-9. PubMed ID: 1315288
    [Abstract] [Full Text] [Related]

  • 6. [Macrophages do not inhibit the nuclei of nonmalignant proliferating cells entering into DNA synthesis in heterokaryons].
    Egorov EE, Prudovskiĭ IA, Zelenin AV.
    Dokl Akad Nauk SSSR; 1985 Jun; 280(4):1016-9. PubMed ID: 3987505
    [No Abstract] [Full Text] [Related]

  • 7. Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I.
    D'Arpa P, Liu LF.
    Exp Cell Res; 1995 Mar; 217(1):125-31. PubMed ID: 7867711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K, Murakami T, Ogino T, Takahashi M, Kawasaki S.
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [Abstract] [Full Text] [Related]

  • 10. The production of antibodies to DNA in normal mice following immunization with poly(ADP-ribose).
    Sibley JT, Braun RP, Lee JS.
    Clin Exp Immunol; 1986 Jun; 64(3):563-9. PubMed ID: 3791691
    [Abstract] [Full Text] [Related]

  • 11. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Poot M, Hiller KH, Heimpel S, Hoehn H.
    Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
    [Abstract] [Full Text] [Related]

  • 12. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
    Hanai N, Shitara K, Yoshida H.
    Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
    [Abstract] [Full Text] [Related]

  • 13. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
    Miller MR, Heyneman C, Walker S, Ulrich RG.
    J Immunol; 1986 Mar 01; 136(5):1791-5. PubMed ID: 3950402
    [Abstract] [Full Text] [Related]

  • 14. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC, McNally NJ, Shrieve DC, Kärcher H.
    Cytometry; 1985 Nov 01; 6(6):620-6. PubMed ID: 4064842
    [Abstract] [Full Text] [Related]

  • 15. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity.
    Yoshinari T, Matsumoto M, Arakawa H, Okada H, Noguchi K, Suda H, Okura A, Nishimura S.
    Cancer Res; 1995 Mar 15; 55(6):1310-5. PubMed ID: 7882328
    [Abstract] [Full Text] [Related]

  • 16. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K, Fujimoto M, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, Ogawa F, Shimizu K, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2008 Jun 15; 67(6):867-72. PubMed ID: 17823201
    [Abstract] [Full Text] [Related]

  • 17. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
    Yoshinari T, Yamada A, Uemura D, Nomura K, Arakawa H, Kojiri K, Yoshida E, Suda H, Okura A.
    Cancer Res; 1993 Feb 01; 53(3):490-4. PubMed ID: 8381047
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activity.
    Oddou P, Schmidt U, Knippers R, Richter A.
    Eur J Biochem; 1988 Nov 15; 177(3):523-9. PubMed ID: 2461859
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
    Wagener C, Yang YH, Crawford FG, Shively JE.
    J Immunol; 1983 May 15; 130(5):2308-15. PubMed ID: 6187849
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
    Li G, Hu J, Zhou G, Zhu J, Sun Q.
    Chin Med J (Engl); 2001 Sep 15; 114(9):962-6. PubMed ID: 11780392
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 2.